{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T03:53:48Z","timestamp":1788494028167,"version":"build-2803163510"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2016YFC0906300"],"award-info":[{"award-number":["2016YFC0906300"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Artificial Intelligence in Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.artmed.2025.103301","type":"journal-article","created":{"date-parts":[[2025,11,16]],"date-time":"2025-11-16T20:35:14Z","timestamp":1763325314000},"page":"103301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A deep representation learning algorithm on drug-target interaction to screen novel drug candidates for Alzheimer's disease"],"prefix":"10.1016","volume":"171","author":[{"given":"Xin","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.artmed.2025.103301_bb0005","first-page":"149","article-title":"Epidemiology of Alzheimer's disease: latest trends","volume":"70","author":"Dumurgier","year":"2020","journal-title":"Rev Prat"},{"key":"10.1016\/j.artmed.2025.103301_bb0010","series-title":"Handbook of Clinical Neurology","first-page":"231","article-title":"Chapter 13 - Alzheimer's disease","author":"Soria Lopez","year":"2019"},{"key":"10.1016\/j.artmed.2025.103301_bb0015","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Naghavi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.artmed.2025.103301_bb0020","doi-asserted-by":"crossref","first-page":"38255","DOI":"10.1002\/alz.038255","article-title":"World Alzheimer Report 2019: attitudes to dementia, a global survey","volume":"16","author":"Lynch","year":"2020","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.artmed.2025.103301_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.artmed.2025.103301_bb0030","doi-asserted-by":"crossref","first-page":"173554","DOI":"10.1016\/j.ejphar.2020.173554","article-title":"Alzheimer's disease: recent treatment strategies","volume":"887","author":"Vaz","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.artmed.2025.103301_bb0035","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/13543784.2017.1323868","article-title":"Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015","volume":"26","author":"Mehta","year":"2017","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.artmed.2025.103301_bb0040","first-page":"34","article-title":"Alzheimer disease","volume":"13","author":"Knopman","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"1","key":"10.1016\/j.artmed.2025.103301_bb0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrn1588","article-title":"Choline transporters, cholinergic transmission and cognition","volume":"6","author":"Sarter","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.artmed.2025.103301_bb0050","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/joim.12191","article-title":"Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014","volume":"275","author":"Schneider","year":"2014","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.artmed.2025.103301_bb0055","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1021\/acs.chemrev.8b00138","article-title":"Development of multifunctional molecules as potential therapeutic candidates for Alzheimer's Disease, Parkinson's Disease, and amyotrophic lateral sclerosis in the last decade","volume":"119","author":"Savelieff","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.artmed.2025.103301_bb0060","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2174\/1567205015666180813150703","article-title":"Insights into the drug repositioning applied to the Alzheimer's disease treatment and future perspectives","volume":"15","author":"De Castro","year":"2018","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.artmed.2025.103301_bb0065","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3233\/JAD-200049","article-title":"Drug repositioning for Alzheimer's Disease: finding hidden clues in old drugs","volume":"74","author":"Ihara","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.artmed.2025.103301_bb0070","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.drudis.2017.10.009","article-title":"Computational drug repositioning for rare diseases in the era of precision medicine","volume":"23","author":"Delavan","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.artmed.2025.103301_bb0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.artmed.2025.103301_bb0080","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.artmed.2025.103301_bb0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","article-title":"Tau and neurodegenerative disease: the story so far","volume":"12","author":"Iqbal","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.artmed.2025.103301_bb0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2-based therapy for Alzheimer\u2019s disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.artmed.2025.103301_bb0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.artmed.2025.103301_bb0100","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.conb.2018.04.027","article-title":"Tau-mediated synaptic and neuronal dysfunction in neurodegenerative disease","volume":"51","author":"Tracy","year":"2018","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.artmed.2025.103301_bb0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.conb.2021.03.003","article-title":"A current view on Tau protein phosphorylation in Alzheimer's disease","volume":"69","author":"Wegmann","year":"2021","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.artmed.2025.103301_bb0110","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1212\/01.WNL.0000063311.58879.01","article-title":"Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer\u2019s disease","volume":"60","author":"Giannakopoulos","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.artmed.2025.103301_bb0115","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/s41593-020-0599-5","article-title":"The multiplex model of the genetics of Alzheimer's disease","volume":"23","author":"Sims","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.artmed.2025.103301_bb0120","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13024-021-00474-z","article-title":"Proteomic landscape of Alzheimer\u2019s Disease: novel insights into pathogenesis and biomarker discovery","volume":"16","author":"Bai","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.artmed.2025.103301_bb0125","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","article-title":"A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease","volume":"53","author":"Wightman","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.artmed.2025.103301_bb0130","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","article-title":"New insights into the genetic etiology of Alzheimer's disease and related dementias","volume":"54","author":"Bellenguez","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.artmed.2025.103301_bb0135","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.artmed.2025.103301_bb0140","doi-asserted-by":"crossref","first-page":"16873","DOI":"10.1002\/jcp.28372","article-title":"Genetic discoveries and advances in late-onset Alzheimer\u2019s disease","volume":"234","author":"Rezazadeh","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.artmed.2025.103301_bb0145","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3233\/JAD-180833","article-title":"Stem cell-derived neurons as cellular models of sporadic Alzheimer's disease","volume":"67","author":"Foveau","year":"2019","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.artmed.2025.103301_bb0150","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s40265-023-01938-w","article-title":"Alzheimer\u2019s disease: novel targets and investigational drugs for disease modification","volume":"83","author":"Cummings","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.artmed.2025.103301_bb0155","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1038\/s41380-021-01251-6","article-title":"Identification of novel drug targets for Alzheimer's disease by integrating genetics and proteomes from brain and blood","volume":"26","author":"Ou","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.artmed.2025.103301_bb0160","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/scitranslmed.aag1166","article-title":"The druggable genome and support for target identification and validation in drug development","volume":"9","author":"Finan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.artmed.2025.103301_bb0165","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13195-021-00951-z","article-title":"Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease","volume":"14","author":"Fang","year":"2022","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.artmed.2025.103301_bb0170","doi-asserted-by":"crossref","first-page":"102206","DOI":"10.1016\/j.cbpa.2022.102206","article-title":"Network analysis of genome-wide association studies for drug target prioritisation","volume":"71","author":"Barrio-Hernandez","year":"2022","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.artmed.2025.103301_bb0175","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.artmed.2025.103301_bb0180","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","article-title":"Computational approaches streamlining drug discovery","volume":"616","author":"Sadybekov","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.artmed.2025.103301_bb0185","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/d41586-023-02896-9","article-title":"AI can help to speed up drug discovery - but only if we give it the right data","volume":"621","author":"Mock","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.artmed.2025.103301_bb0190","doi-asserted-by":"crossref","first-page":"102172","DOI":"10.1016\/j.arr.2023.102172","article-title":"Machine learning in Alzheimer's disease drug discovery and target identification","volume":"93","author":"Geng","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.artmed.2025.103301_bb0195","doi-asserted-by":"crossref","first-page":"1036552","DOI":"10.3389\/fnmol.2022.1036552","article-title":"Recognizing novel drugs against Keap1 in Alzheimer's disease using machine learning grounded computational studies","volume":"15","author":"Mukerjee","year":"2022","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.artmed.2025.103301_bb0200","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41467-021-21330-0","article-title":"Machine learning identifies candidates for drug repurposing in Alzheimer's disease","volume":"12","author":"Rodriguez","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.artmed.2025.103301_bb0205","first-page":"1301","article-title":"Efficient Estimation of Word Representations in Vector Space","volume":"2","author":"Tomas Mikolov","year":"2013"},{"key":"10.1016\/j.artmed.2025.103301_bb0210","first-page":"1188","article-title":"Distributed representations of words and phrases and their compositionality","volume":"31","author":"Quoc","year":"2014","journal-title":"arXiv"},{"key":"10.1016\/j.artmed.2025.103301_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13755-018-0062-0","article-title":"Neural networks for mining the associations between diseases and symptoms in clinical notes","volume":"7","author":"Shah","year":"2018","journal-title":"Health Inf. Sci. Syst."},{"key":"10.1016\/j.artmed.2025.103301_bb0220","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/bib\/bbab228","article-title":"LSTM-PHV: prediction of human-virus protein\u2013protein interactions by LSTM with word2vec","volume":"22","author":"Tsukiyama","year":"2021","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.artmed.2025.103301_bb0225","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1140\/epjds\/s13688-022-00344-8","article-title":"Time-varying graph representation learning via higher-order skip-gram with negative sampling","volume":"11","author":"Piaggesi","year":"2022","journal-title":"EPJ Data Sci."},{"key":"10.1016\/j.artmed.2025.103301_bb0230","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.artmed.2025.103301_bb0235","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.artmed.2025.103301_bb0240","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.omtn.2023.02.019","article-title":"Artificial intelligence for drug discovery: resources, methods, and applications","volume":"31","author":"Chen","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.artmed.2025.103301_bb0245","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/nar\/gkw1012","article-title":"MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search","volume":"45","author":"Rappaport","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.artmed.2025.103301_bb0250","first-page":"845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Pi\u00f1ero","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.artmed.2025.103301_bb0255","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13195-017-0252-z","article-title":"Analyzing the genes related to Alzheimer's disease via a network and pathway-based approach","volume":"9","author":"Hu","year":"2017","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.artmed.2025.103301_bb0260","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/bib\/bbz157","article-title":"Machine learning approaches and databases for prediction of drug-target interaction: a survey paper","volume":"22","author":"Bagherian","year":"2021","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.artmed.2025.103301_bb0265","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1109\/TNNLS.2020.3028099","article-title":"Seeds: sampling-enhanced embeddings","volume":"33","author":"Gong","year":"2022","journal-title":"IEEE Trans Neural Netw Learn Syst"},{"key":"10.1016\/j.artmed.2025.103301_bb0270","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10916-019-1397-z","article-title":"Breast cancer diagnosis using feature ensemble learning based on stacked sparse autoencoders and softmax regression","volume":"43","author":"Kadam","year":"2019","journal-title":"J. Med. Syst."},{"key":"10.1016\/j.artmed.2025.103301_bb0275","doi-asserted-by":"crossref","first-page":"1573543","DOI":"10.1155\/2020\/1573543","article-title":"Prediction of drug side effects with a refined negative sample selection strategy","volume":"2020","author":"Liang","year":"2020","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.artmed.2025.103301_bb0280","doi-asserted-by":"crossref","first-page":"1747413","DOI":"10.1155\/2020\/1747413","article-title":"A modified skip-gram algorithm for extracting drug-drug interactions from AERS reports","volume":"2020","author":"Wang","year":"2020","journal-title":"Comput Math Methods Med"},{"key":"10.1016\/j.artmed.2025.103301_bb0285","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1080\/17470218.2016.1195417","article-title":"Extrapolating human judgments from skip-gram vector representations of word meaning","volume":"70","author":"Hollis","year":"2017","journal-title":"Q. J. Exp. Psychol."},{"key":"10.1016\/j.artmed.2025.103301_bb0290","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nchem.2889","article-title":"Structure-based inhibitors of tau aggregation","volume":"10","author":"Seidler","year":"2018","journal-title":"Nat. Chem."},{"key":"10.1016\/j.artmed.2025.103301_bb0295","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/nar\/gky1033","article-title":"PubChem 2019 update: improved access to chemical data","volume":"47","author":"Kim","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.artmed.2025.103301_bb0300","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.artmed.2025.103301_bb0305","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","article-title":"Ligand docking and binding site analysis with PyMOL and Autodock\/Vina","volume":"24","author":"Seeliger","year":"2010","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.artmed.2025.103301_bb0310","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.artmed.2025.103301_bb0315","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1080\/07391102.2020.1796811","article-title":"Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development","volume":"39","author":"Pandey","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.artmed.2025.103301_bb0320","doi-asserted-by":"crossref","first-page":"11081","DOI":"10.15252\/msb.202211081","article-title":"Benchmarking AlphaFold-enabled molecular docking predictions for antibiotic discovery","volume":"18","author":"Wong","year":"2022","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.artmed.2025.103301_bb0325","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1093\/bioinformatics\/btaa563","article-title":"Screening novel drug candidates for Alzheimer's disease by an integrated network and transcriptome analysis","volume":"36","author":"Peng","year":"2020","journal-title":"Bioinformatics"},{"key":"10.1016\/j.artmed.2025.103301_bb0330","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The connectivity map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.artmed.2025.103301_bb0335","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tips.2020.04.008","article-title":"A perspective on multi-target drugs for Alzheimer's disease","volume":"41","author":"Benek","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.artmed.2025.103301_bb0340","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.abb.2006.02.009","article-title":"Glutathione S-transferase P1-1 expression modulates sensitivity of human kidney 293 cells to photodynamic therapy with hypericin","volume":"449","author":"Dabrowski","year":"2006","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.artmed.2025.103301_bb0345","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cbi.2010.07.007","article-title":"Inhibition characteristics of hypericin on rat small intestine glutathione-S-transferases","volume":"188","author":"Tuna","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.artmed.2025.103301_bb0350","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK fusion-positive cancers and TRK inhibitor therapy","volume":"15","author":"Cocco","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.artmed.2025.103301_bb0355","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1021\/acs.biochem.9b00301","article-title":"Steering the lipid transfer to unravel the mechanism of cholesteryl ester transfer protein inhibition","volume":"58","author":"Dixit","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.artmed.2025.103301_bb0360","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11883-023-01087-1","article-title":"Structure-based mechanism and inhibition of cholesteryl ester transfer protein","volume":"25","author":"Xue","year":"2023","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.artmed.2025.103301_bb0365","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","article-title":"Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs","volume":"281","author":"Agrawal","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.artmed.2025.103301_bb0370","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.3390\/molecules26102843","article-title":"Modulation of \u03b3-secretase activity by a carborane-based flurbiprofen analogue","volume":"26","author":"Saretz","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.artmed.2025.103301_bb0375","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.2147\/NDT.S312648","article-title":"Milrinone ameliorates the neuroinflammation and memory function of Alzheimer's disease in an APP\/PS1 mouse model","volume":"17","author":"Chen","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.artmed.2025.103301_bb0380","doi-asserted-by":"crossref","first-page":"110822","DOI":"10.1016\/j.fct.2019.110822","article-title":"Phosphodiesterase inhibitors say NO to Alzheimer's disease","volume":"134","author":"Nabavi","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.artmed.2025.103301_bb0385","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.exger.2016.10.013","article-title":"A novel mechanism of non-feminizing estrogens in neuroprotection","volume":"94","author":"Engler-Chiurazzi","year":"2017","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.artmed.2025.103301_bb0390","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1507\/endocrj.50.361","article-title":"Estrogen and non-feminizing estrogen for Alzheimer's disease","volume":"50","author":"Honjo","year":"2003","journal-title":"Endocr. J."},{"key":"10.1016\/j.artmed.2025.103301_bb0395","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/nar\/gkaa1084","article-title":"Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts","volume":"49","author":"Freshour","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.artmed.2025.103301_bb0400","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1093\/nar\/gkad751","article-title":"TTD: Therapeutic Target Database describing target druggability information","volume":"52","author":"Zhou","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.artmed.2025.103301_bb0405","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.drudis.2022.103422","article-title":"Drug repurposing using real-world data","volume":"28","author":"Tan","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.artmed.2025.103301_bb0410","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1109\/TCBB.2022.3144008","article-title":"CPInformer for efficient and robust compound-protein interaction prediction","volume":"20","author":"Hua","year":"2023","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"key":"10.1016\/j.artmed.2025.103301_bb0415","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.1038\/s41467-021-27137-3","article-title":"A unified drug-target interaction prediction framework based on knowledge graph and recommendation system","volume":"12","author":"Ye","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.artmed.2025.103301_bb0420","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/bib\/bbv066","article-title":"Drug-target interaction prediction: databases, web servers and computational models","volume":"17","author":"Chen","year":"2016","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.artmed.2025.103301_bb0425","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fnins.2016.00177","article-title":"One for all? Hitting multiple Alzheimer's disease targets with one drug","volume":"10","author":"Hughes","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.artmed.2025.103301_bb0430","first-page":"1036","article-title":"Evaluation of chemical composition and biological activities of three endemic Hypericum species from Anatolia spectabile and pseudolaeve","volume":"17","author":"Ozkan","year":"2018","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.artmed.2025.103301_bb0435","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1021\/acs.jmedchem.7b00396","article-title":"A kinome-wide selective radiolabeled TrkB\/C inhibitor for in vitro and in vivo neuroimaging: synthesis, preclinical evaluation, and first-in-human","volume":"60","author":"Bernard-Gauthier","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.artmed.2025.103301_bb0440","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00018-005-5406-7","article-title":"Lipid-lowering drugs","volume":"63","author":"Pahan","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.artmed.2025.103301_bb0445","doi-asserted-by":"crossref","first-page":"16023","DOI":"10.1074\/jbc.275.21.16023","article-title":"Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages","volume":"275","author":"Ishii","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.artmed.2025.103301_bb0450","doi-asserted-by":"crossref","first-page":"22915","DOI":"10.1002\/jbt.22915","article-title":"A new underlying mechanism for the neuroprotective effect of bosutinib: reverting toxicity-induced PARylation in SIN1-mediated neurotoxicity","volume":"35","author":"Yilmaz","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.artmed.2025.103301_bb0455","doi-asserted-by":"crossref","first-page":"11491","DOI":"10.1002\/anie.202002574","article-title":"Discovery of chemicals to either clear or indicate amyloid aggregates by targeting memory-impairing anti-parallel A\u03b2 dimers","volume":"59","author":"Lee","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.artmed.2025.103301_bb0460","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1038\/s41591-023-02543-w","article-title":"Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial","volume":"29","author":"Gonzales","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.artmed.2025.103301_bb0465","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S1474-4422(16)00099-5","article-title":"Heat shock proteins as potential targets for protective strategies in neurodegeneration","volume":"15","author":"Kampinga","year":"2016","journal-title":"The Lancet Neurology"},{"key":"10.1016\/j.artmed.2025.103301_bb0470","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2174\/1570159X16666180828100002","article-title":"Current progress on peroxisome proliferator-activated receptor gamma agonist as an emerging therapeutic approach for the treatment of Alzheimer's disease: an update","volume":"17","author":"Khan","year":"2019","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.artmed.2025.103301_bb0475","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/brb3.1973","article-title":"Enhancement of select cognitive domains with rosiglitazone implicates dorsal hippocampus circuitry sensitive to PPAR\u03b3 agonism in an Alzheimer's mouse model","volume":"11","author":"Cortez","year":"2021","journal-title":"Brain Behav"}],"container-title":["Artificial Intelligence in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0933365725002362?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0933365725002362?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T10:23:46Z","timestamp":1766139826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0933365725002362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":95,"alternative-id":["S0933365725002362"],"URL":"https:\/\/doi.org\/10.1016\/j.artmed.2025.103301","relation":{},"ISSN":["0933-3657"],"issn-type":[{"value":"0933-3657","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A deep representation learning algorithm on drug-target interaction to screen novel drug candidates for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Artificial Intelligence in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.artmed.2025.103301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103301"}}